| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0a0a24b90627f4084e49a56d4d5268d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate |
1996-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbce602b916bfe199504185cf7da4193 |
| publicationDate |
2008-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2251353-C |
| titleOfInvention |
Transdermal delivery device for azapirone compounds |
| abstract |
In accordance with the present invention, a transdermal azapirone device is provided for administering therapeutically effective amounts of an azapirone into the blood at a controlled rate over a prolonged period of time. The present invention is a transdermal device comprising an azapirone and a stabilizing agent effective to inhibit recrystallization of the azapirone within the transdermal device. |
| priorityDate |
1996-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |